awacke1/LOINC-Clinical-Terminology · Datasets at Hugging Face

LOINC_NUM stringlengths 3 8	COMPONENT stringlengths 2 246	PROPERTY stringlengths 1 29	TIME_ASPCT stringlengths 1 15	SYSTEM stringlengths 1 106	SCALE_TYP stringclasses 10 values	METHOD_TYP stringlengths 1 57 ⌀	CLASS stringlengths 2 24	CLASSTYPE int64 1 4	LONG_COMMON_NAME stringlengths 3 254	SHORTNAME stringlengths 2 51 ⌀	EXTERNAL_COPYRIGHT_NOTICE stringlengths 39 2.6k ⌀	STATUS stringclasses 4 values	VersionFirstReleased stringlengths 1 7	VersionLastChanged stringlengths 1 5
97084-8	Effect of Facebook as source of information on mental health	Find	Pt	^Patient	Ord	null	SURVEY.COVID	4	Effect of Facebook as source of information on mental health	null	null	ACTIVE	2.70	2.71
97085-5	Effect of Instagram or Snapchat as source of information on mental health	Find	Pt	^Patient	Ord	null	SURVEY.COVID	4	Effect of Instagram or Snapchat as source of information on mental health	null	null	ACTIVE	2.70	2.71
97086-3	Effect of Twitter as source of information on mental health	Find	Pt	^Patient	Ord	null	SURVEY.COVID	4	Effect of Twitter as source of information on mental health	null	null	ACTIVE	2.70	2.71
97087-1	Effect of social media (e.g., TikTok, Reddit) as source of information on mental health	Find	Pt	^Patient	Ord	null	SURVEY.COVID	4	Effect of social media (e.g., TikTok, Reddit) as source of information on mental health	null	null	ACTIVE	2.70	2.71
97088-9	How often friends, family or neighbors used as source of information for COVID-19	Find	Pt	^Patient	Ord	null	SURVEY.COVID	4	How often friends, family or neighbors used as source of information for COVID-19	null	null	ACTIVE	2.70	2.71
9708-9	Coxiella burnetii phase 1 Ab.IgG	Titr	Pt	Ser	Qn	null	MICRO	1	Coxiella burnetii phase 1 IgG Ab [Titer] in Serum	C burnet Ph1 IgG Titr Ser	null	ACTIVE	1.0i	2.73
97089-7	How often medical providers used as source of information for COVID-19	Find	Pt	^Patient	Ord	null	SURVEY.COVID	4	How often medical providers used as source of information for COVID-19	null	null	ACTIVE	2.70	2.71
97090-5	How often local government officials used as source of information for COVID-19	Find	Pt	^Patient	Ord	null	SURVEY.COVID	4	How often local government officials used as source of information for COVID-19	null	null	ACTIVE	2.70	2.71
97091-3	How often Federal Government used as source of information for COVID-19	Find	Pt	^Patient	Ord	null	SURVEY.COVID	4	How often Federal Government used as source of information for COVID-19	null	null	ACTIVE	2.70	2.71
97092-1	How often medical or health websites used as source of information for COVID-19	Find	Pt	^Patient	Ord	null	SURVEY.COVID	4	How often medical or health websites used as source of information for COVID-19	null	null	ACTIVE	2.70	2.71
97093-9	How often print or online news used as source of information for COVID-19	Find	Pt	^Patient	Ord	null	SURVEY.COVID	4	How often print or online news used as source of information for COVID-19	null	null	ACTIVE	2.70	2.71
97094-7	How often TV or radio used as source of information for COVID-19	Find	Pt	^Patient	Ord	null	SURVEY.COVID	4	How often TV or radio used as source of information for COVID-19	null	null	ACTIVE	2.70	2.71
97095-4	How often social media used as source of information for COVID-19	Find	Pt	^Patient	Ord	null	SURVEY.COVID	4	How often social media used as source of information for COVID-19	null	null	ACTIVE	2.70	2.71
97096-2	COVID-19 experiences - media use panel	-	Pt	^Patient	-	COVEX	PANEL.SURVEY.COVID	4	COVID-19 experiences - media use panel [COVEX]	null	null	ACTIVE	2.70	2.71
9709-7	Coxiella burnetii phase 2 Ab.IgG	Titr	Pt	Ser	Qn	null	MICRO	1	Coxiella burnetii phase 2 IgG Ab [Titer] in Serum	C burnet Ph2 IgG Titr Ser	null	ACTIVE	1.0i	2.73
97097-0	SARS coronavirus 2 Ag	PrThr	Pt	Respiratory.upper	Ord	IA.rapid	MICRO	1	SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay	SARS-CoV-2 Ag Upper resp Ql IA.rapid	null	ACTIVE	2.70	2.7
97098-8	SARS coronavirus 2 Nsp2 gene	PrThr	Pt	Respiratory.upper	Ord	Probe.amp.tar	MICRO	1	SARS-CoV-2 (COVID-19) Nsp2 gene [Presence] in Upper respiratory specimen by NAA with probe detection	SARS-CoV-2 Nsp2 Upper resp Ql NAA+probe	null	ACTIVE	2.70	2.7
97099-6	Influenza virus A & Influenza virus B & SARS coronavirus 2 Ag panel	-	Pt	Respiratory.upper	-	IA.rapid	PANEL.MICRO	1	Influenza virus A and B and SARS-CoV-2 (COVID-19) Ag panel - Upper respiratory specimen by Rapid immunoassay	FLUABV+SARS-CoV2 Ag Pnl Up resp IA.rapid	null	ACTIVE	2.70	2.7
97100-2	Colonoscopy and endoscopic ultrasound study	Find	Pt	Lower GI tract	Doc	Colonoscopy+US	ENDO.GI	2	Colonoscopy+US Study	Colonoscopy+US Study	null	ACTIVE	2.70	2.72
97101-0	Flexible sigmoidoscopy and endoscopic ultrasound study	Find	Pt	Lower GI tract	Doc	Flexible sigmoidoscopy+US	ENDO.GI	2	Flexible sigmoidoscopy+US Study	FSIG+US Study	null	ACTIVE	2.70	2.72
97102-8	Tau protein.phosphorylated 181/Amyloid beta 42 peptide	Ratio	Pt	CSF	Qn	null	CHEM	1	Phosphorylated tau 181/Amyloid beta 42 peptide [Ratio] in Cerebral spinal fluid	p-tau181/AL beta42 CSF-Rto	null	ACTIVE	2.70	2.7
97103-6	Zygosity	Type	Pt	^Fetuses	Nom	Molgen	MOLPATH	1	Zygosity [Type] in Fetuses by Molecular genetics method	Zygosity in Fetuses	null	ACTIVE	2.70	2.7
97104-4	SARS coronavirus 2 ORF1ab region	ACnc	Pt	Respiratory.upper	Qn	Probe.amp.tar	MICRO	1	SARS-CoV-2 (COVID-19) ORF1ab region [Units/volume] (viral load) in Upper respiratory specimen by NAA with probe detection	SARS-CoV-2 ORF1ab U resp NAA+probe-aCnc	null	ACTIVE	2.70	2.7
9710-5	Coxiella burnetii phase 1 Ab.IgM	Titr	Pt	Ser	Qn	null	MICRO	1	Coxiella burnetii phase 1 IgM Ab [Titer] in Serum	C burnet Ph1 IgM Titr Ser	null	ACTIVE	1.0i	2.73
97105-1	Chemokine (C-C motif) ligand 2	MCnc	Pt	Urine	Qn	IA	CHEM	1	Chemokine (C-C motif) ligand 2 [Mass/volume] in Urine by Immunoassay	CCL2 Ur IA-mCnc	null	ACTIVE	2.70	2.7
97106-9	Hepatitis A virus cellular receptor 1	MCnc	Pt	Urine	Qn	IA	CHEM	1	Hepatitis A virus cellular receptor 1 [Mass/volume] in Urine by Immunoassay	HAVcr-1 Ur IA-mCnc	null	ACTIVE	2.70	2.7
97107-7	Fibroblast growth factor 19	MCnc	Pt	Ser/Plas	Qn	IA	CHEM	1	Fibroblast growth factor 19 [Mass/volume] in Serum or Plasma by Immunoassay	FGF-19 SerPl IA-mCnc	null	ACTIVE	2.70	2.7
97108-5	Employment status in the 2W prior to COVID-19 outbreak	Find	Pt	^Patient	Nom	null	SURVEY.COVID	4	Employment status in the 2 weeks prior to COVID-19 outbreak	null	null	ACTIVE	2.70	2.71
97109-3	New employment during the COVID-19 outbreak	Find	Pt	^Patient	Ord	null	SURVEY.COVID	4	New employment during the COVID-19 outbreak	null	null	ACTIVE	2.70	2.71
97110-1	Work setting in the 2W before the COVID-19 outbreak	Find	Pt	^Patient	Nom	null	SURVEY.COVID	4	Work setting in the 2 weeks before the COVID-19 outbreak	null	null	ACTIVE	2.70	2.71
97111-9	Job loss during the COVID-19 outbreak	Find	Pt	^Patient	Nom	null	SURVEY.COVID	4	Job loss during the COVID-19 outbreak	null	null	ACTIVE	2.70	2.71
97112-7	Worked during the COVID-19 outbreak	Find	Pt	^Patient	Ord	null	SURVEY.COVID	4	Worked during the COVID-19 outbreak	null	null	ACTIVE	2.70	2.71
9711-3	Coxiella burnetii phase 2 Ab.IgM	Titr	Pt	Ser	Qn	null	MICRO	1	Coxiella burnetii phase 2 IgM Ab [Titer] in Serum	C burnet Ph2 IgM Titr Ser	null	ACTIVE	1.0i	2.73
97113-5	Significant job changes during the COVID-19 outbreak	Find	Pt	^Patient	Nom	null	SURVEY.COVID	4	Significant job changes during the COVID-19 outbreak	null	null	ACTIVE	2.70	2.71
97114-3	Work setting during the COVID-19 outbreak	Find	Pt	^Patient	Nom	null	SURVEY.COVID	4	Work setting during the COVID-19 outbreak	null	null	ACTIVE	2.70	2.71
97115-0	Student in the few weeks before COVID-19 outbreak	Find	Pt	^Patient	Ord	null	SURVEY.COVID	4	Student in the few weeks before COVID-19 outbreak	null	null	ACTIVE	2.70	2.71
97116-8	Student during the COVID-19 outbreak	Find	Pt	^Patient	Ord	null	SURVEY.COVID	4	Student during the COVID-19 outbreak	null	null	ACTIVE	2.70	2.71
97117-6	School has offered classes remotely during the COVID-19 outbreak	Find	Pt	^Patient	Ord	null	SURVEY.COVID	4	School has offered classes remotely during the COVID-19 outbreak	null	null	ACTIVE	2.70	2.71
97118-4	Increase or decrease in schoolwork during the COVID-19 outbreak	Find	Pt	^Patient	Ord	null	SURVEY.COVID	4	Increase or decrease in schoolwork during the COVID-19 outbreak	null	null	ACTIVE	2.70	2.71
97119-2	Difficulty getting work or schoolwork done because of other responsibilities at home during the COVID-19 outbreak	Find	Pt	^Patient	Ord	null	SURVEY.COVID	4	Difficulty getting work or schoolwork done because of other responsibilities at home during the COVID-19 outbreak	null	null	ACTIVE	2.70	2.71
971-2	Weak D Ag	PrThr	Pt	RBC^Donor	Ord	null	BLDBK	1	Weak D Ag [Presence] on Red Blood Cells from Donor	Weak D Ag RBC Donr Ql	null	ACTIVE	1.0	2.7
97120-0	Difficulty getting work or schoolwork done because of your home environment during the COIVD-19 outbreak	Find	Pt	^Patient	Ord	null	SURVEY.COVID	4	Difficulty getting work or schoolwork done because of your home environment during the COIVD-19 outbreak	null	null	ACTIVE	2.70	2.71
9712-1	Shigella boydii Ab	Titr	Pt	Ser	Qn	Comp fix	MICRO	1	Shigella boydii Ab [Titer] in Serum by Complement fixation	S boydii Ab Titr Ser CF	null	ACTIVE	1.0i	2.73
97121-8	Household job or income loss due to the COVID-19 outbreak	Find	Pt	^Patient	Ord	null	SURVEY.COVID	4	Household job or income loss due to the COVID-19 outbreak	null	null	ACTIVE	2.70	2.71
97122-6	Person who lost job or income due to COVID-19 outbreak	Find	Pt	^Household member	Nom	null	SURVEY.COVID	4	Household member who lost job or income due to COVID-19 outbreak	null	null	ACTIVE	2.70	2.71
97123-4	COVID-19 experiences - employment and school changes panel	-	Pt	^Patient	-	COVEX	PANEL.SURVEY.COVID	4	COVID-19 experiences - employment and school changes panel [COVEX]	null	null	ACTIVE	2.70	2.71
97124-2	How helpful has texting, calling or video-calling family members or friends been as a coping strategy during the COVID-19 outbreak	Find	Pt	^Patient	Ord	null	SURVEY.COVID	4	How helpful has texting, calling or video-calling family members or friends been as a coping strategy during the COVID-19 outbreak	null	null	ACTIVE	2.70	2.71
97125-9	How helpful has talking to a therapist been as a coping strategy during the COVID-19 outbreak	Find	Pt	^Patient	Ord	null	SURVEY.COVID	4	How helpful has talking to a therapist been as a coping strategy during the COVID-19 outbreak	null	null	ACTIVE	2.70	2.71
97126-7	How helpful has exercising or walking been as a coping strategy during the COVID-19 outbreak	Find	Pt	^Patient	Ord	null	SURVEY.COVID	4	How helpful has exercising or walking been as a coping strategy during the COVID-19 outbreak	null	null	ACTIVE	2.70	2.71
97127-5	How helpful has cooking or baking been as a coping strategy during the COVID-19 outbreak	Find	Pt	^Patient	Ord	null	SURVEY.COVID	4	How helpful has cooking or baking been as a coping strategy during the COVID-19 outbreak	null	null	ACTIVE	2.70	2.71
97128-3	How helpful have arts and crafts projects been as a coping strategy during the COVID-19 outbreak	Find	Pt	^Patient	Ord	null	SURVEY.COVID	4	How helpful have arts and crafts projects been as a coping strategy during the COVID-19 outbreak	null	null	ACTIVE	2.70	2.71
97129-1	How helpful has cleaning or doing household chores been as a coping strategy during the COVID-19 outbreak	Find	Pt	^Patient	Ord	null	SURVEY.COVID	4	How helpful has cleaning or doing household chores been as a coping strategy during the COVID-19 outbreak	null	null	ACTIVE	2.70	2.71
97130-9	How helpful has playing games with family members been as a coping strategy during the COVID-19 outbreak	Find	Pt	^Patient	Ord	null	SURVEY.COVID	4	How helpful has playing games with family members been as a coping strategy during the COVID-19 outbreak	null	null	ACTIVE	2.70	2.71
97131-7	How helpful has playing online games been as a coping strategy during the COVID-19 outbreak	Find	Pt	^Patient	Ord	null	SURVEY.COVID	4	How helpful has playing online games been as a coping strategy during the COVID-19 outbreak	null	null	ACTIVE	2.70	2.71
97132-5	How helpful has virtual entertainment been as a coping strategy during the COVID-19 outbreak	Find	Pt	^Patient	Ord	null	SURVEY.COVID	4	How helpful has virtual entertainment been as a coping strategy during the COVID-19 outbreak	null	null	ACTIVE	2.70	2.71
97133-3	Helpful coping strategy used during the COVID-19 outbreak	Find	Pt	^Patient	Nom	null	SURVEY.COVID	4	Helpful coping strategy used during the COVID-19 outbreak	null	null	ACTIVE	2.70	2.71
97134-1	How helpful was your coping strategy during the COVID-19 outbreak	Find	Pt	^Patient	Ord	null	SURVEY.COVID	4	How helpful was your coping strategy during the COVID-19 outbreak	null	null	ACTIVE	2.70	2.71
97135-8	Impact of COVID-19 outbreak on life	Find	Pt	^Patient	Ord	null	SURVEY.COVID	4	Impact of COVID-19 outbreak on life	null	null	ACTIVE	2.70	2.71
97136-6	How helpful has texting, calling or video-calling family members or friends been as a coping strategy to your child during the COVID-19 outbreak	Find	Pt	^Patient	Ord	null	SURVEY.COVID	4	How helpful has texting, calling or video-calling family members or friends been as a coping strategy to your child during the COVID-19 outbreak	null	null	ACTIVE	2.70	2.71
97137-4	How helpful has virtual learning or school been as a coping strategy to your child during the COVID-19 outbreak	Find	Pt	^Patient	Ord	null	SURVEY.COVID	4	How helpful has virtual learning or school been as a coping strategy to your child during the COVID-19 outbreak	null	null	ACTIVE	2.70	2.71
97138-2	How helpful has talking to a therapist been as a coping strategy to your child during the COVID-19 outbreak	Find	Pt	^Patient	Ord	null	SURVEY.COVID	4	How helpful has talking to a therapist been as a coping strategy to your child during the COVID-19 outbreak	null	null	ACTIVE	2.70	2.71
9713-9	Shigella dysenteriae Ab	Titr	Pt	Ser	Qn	Comp fix	MICRO	1	Shigella dysenteriae Ab [Titer] in Serum by Complement fixation	S dysenter Ab Titr Ser CF	null	ACTIVE	1.0i	2.73
97139-0	How helpful has exercising or walking been as a coping strategy to your child during the COVID-19 outbreak	Find	Pt	^Patient	Ord	null	SURVEY.COVID	4	How helpful has exercising or walking been as a coping strategy to your child during the COVID-19 outbreak	null	null	ACTIVE	2.70	2.71
97140-8	How helpful has cooking or baking been as a coping strategy to your child during the COVID-19 outbreak	Find	Pt	^Patient	Ord	null	SURVEY.COVID	4	How helpful has cooking or baking been as a coping strategy to your child during the COVID-19 outbreak	null	null	ACTIVE	2.70	2.71
97141-6	How helpful have arts and crafts projects been as a coping strategy to your child during the COVID-19 outbreak	Find	Pt	^Patient	Ord	null	SURVEY.COVID	4	How helpful have arts and crafts projects been as a coping strategy to your child during the COVID-19 outbreak	null	null	ACTIVE	2.70	2.71
97142-4	How helpful has playing board games, cards with family members been as a coping strategy to your child during the COVID-19 outbreak	Find	Pt	^Patient	Ord	null	SURVEY.COVID	4	How helpful has playing board games, cards with family members been as a coping strategy to your child during the COVID-19 outbreak	null	null	ACTIVE	2.70	2.71
97143-2	How helpful has playing online games been as a coping strategy to your child during the COVID-19 outbreak	Find	Pt	^Patient	Ord	null	SURVEY.COVID	4	How helpful has playing online games been as a coping strategy to your child during the COVID-19 outbreak	null	null	ACTIVE	2.70	2.71
97144-0	How helpful has virtual entertainment been as a coping strategy to your child during the COVID-19 outbreak	Find	Pt	^Patient	Ord	null	SURVEY.COVID	4	How helpful has virtual entertainment been as a coping strategy to your child during the COVID-19 outbreak	null	null	ACTIVE	2.70	2.71
97145-7	Helpful coping strategy your child used during the COVID-19 outbreak	Find	Pt	^Patient	Nom	null	SURVEY.COVID	4	Helpful coping strategy your child used during the COVID-19 outbreak	null	null	ACTIVE	2.70	2.71
97146-5	How helpful was your child's coping strategy during the COVID-19 outbreak	Find	Pt	^Patient	Ord	null	SURVEY.COVID	4	How helpful was your child's coping strategy during the COVID-19 outbreak	null	null	ACTIVE	2.70	2.71
9714-7	Shigella flexneri Ab	Titr	Pt	Ser	Qn	Comp fix	MICRO	1	Shigella flexneri Ab [Titer] in Serum by Complement fixation	S flexneri Ab Titr Ser CF	null	ACTIVE	1.0i	2.73
97147-3	COVID-19 experiences - coping panel	-	Pt	^Patient	-	COVEX	PANEL.SURVEY.COVID	4	COVID-19 experiences - coping panel [COVEX]	null	null	ACTIVE	2.70	2.71
97148-1	Guanidinoacetate	SCnc	Pt	Urine	Qn	null	CHEM	1	Guanidinoacetate [Moles/volume] in Urine	Guanidinoacetate Ur-sCnc	null	ACTIVE	2.70	2.7
97149-9	Pro prostate specific Ag isoform 2	MCnc	Pt	Ser/Plas	Qn	IA	CHEM	1	proPSA isoform 2 [Mass/volume] in Serum or Plasma by Immunoassay	proPSA isoform 2 SerPl IA-mCnc	null	ACTIVE	2.70	2.7
97150-7	Prostate health index	Score	Pt	Ser/Plas	Qn	Calculated	CHEM	1	Prostate health index in Serum or Plasma by calculation	PHI Score SerPl Calc	null	ACTIVE	2.70	2.7
97151-5	Enterovirus RNA	PrThr	Pt	Ser/Plas	Ord	Non-probe.amp.tar	MICRO	1	Enterovirus RNA [Presence] in Serum or Plasma by NAA with non-probe detection	EV RNA SerPl Ql NAA+non-probe	null	ACTIVE	2.70	2.7
97152-3	Hepatitis B virus core+little e+p22cr Ag	ACnc	Pt	Ser/Plas	Qn	IA	MICRO	1	HBc+HBe+p22cr Ag [Units/volume] in Serum or Plasma by Immunoassay	HBc+HBe+p22cr Ag SerPl IA-aCnc	null	ACTIVE	2.70	2.7
97153-1	Primidone	PrThr	Pt	Urine	Ord	Confirm	DRUG/TOX	1	Primidone [Presence] in Urine by Confirmatory method	Primidone Ur Ql Cfm	null	ACTIVE	2.70	2.7
9715-4	Shigella sonnei Ab	Titr	Pt	Ser	Qn	Comp fix	MICRO	1	Shigella sonnei Ab [Titer] in Serum by Complement fixation	S sonnei Ab Titr Ser CF	null	ACTIVE	1.0i	2.73
97154-9	Ecgonine methyl ester	PrThr	Pt	Urine	Ord	Confirm	DRUG/TOX	1	Ecgonine methyl ester [Presence] in Urine by Confirmatory method	EME Ur Ql Cfm	null	ACTIVE	2.70	2.7
97155-6	SARS coronavirus 2 immunization status	Hx	Pt	^Patient	Nom	null	VACCIN	2	SARS coronavirus 2 (COVID-19) immunization status	SARS-CoV-2 immunization status	null	ACTIVE	2.70	2.7
97156-4	Human papilloma virus 16+18+31+33+35+39+45+51+52+56+58+59+68 DNA	PrThr	Pt	Genital	Ord	Probe.amp.sig	MICRO	1	Human papilloma virus 16+18+31+33+35+39+45+51+52+56+58+59+68 DNA [Presence] in Genital specimen by Probe with signal amplification	HPV I/H Risk DNA Genital Ql Prb+sig amp	null	ACTIVE	2.70	2.7
97157-2	Human papilloma virus 6+11+42+43+44 DNA	PrThr	Pt	Genital	Ord	Probe.amp.sig	MICRO	1	Human papilloma virus 6+11+42+43+44 DNA [Presence] in Genital specimen by Probe with signal amplification	HPV Low Risk DNA Genital Ql Prb+sig amp	null	ACTIVE	2.70	2.7
97158-0	Cytokeratin 8 Ag	PrThr	Pt	Tissue	Ord	Immune stain	PATH	1	Cytokeratin 8 Ag [Presence] in Tissue by Immune stain	CK8 Ag tiss Ql ImStn	null	ACTIVE	2.70	2.7
97159-8	2-Hydroxyethylflurazepam	MCnc	Pt	Urine	Qn	Confirm	DRUG/TOX	1	2-Hydroxyethylflurazepam [Mass/volume] in Urine by Confirmatory method	2-OH-Ethylfluraz Ur Cfm-mCnc	null	ACTIVE	2.70	2.7
97160-6	Norclobazam	MCnc	Pt	Urine	Qn	Confirm	DRUG/TOX	1	Norclobazam [Mass/volume] in Urine by Confirmatory method	Norclobazam Ur Cfm-mCnc	null	ACTIVE	2.70	2.7
97161-4	Amphetamines panel	-	Pt	Urine	-	Confirm	PANEL.DRUG/TOX	1	Amphetamines panel - Urine by Confirmatory method	Amphetamines Pnl Ur Cfm	null	ACTIVE	2.70	2.7
9716-2	Streptococcal hyaluronidase Ab	Titr	Pt	Ser	Qn	null	MICRO	1	Streptococcal hyaluronidase Ab [Titer] in Serum	Str Hyaluronidase Ab Titr Ser	null	ACTIVE	1.0i	2.7
97162-2	Titin Ab	ACnc	Pt	CSF	Qn	Line blot	SERO	1	Titin Ab [Units/volume] in Cerebral spinal fluid by Line blot	Titin Ab CSF Line blot-aCnc	null	ACTIVE	2.70	2.7
97163-0	Theophylline^peak	MCnc	Pt	Ser/Plas	Qn	null	DRUG/TOX	1	Theophylline [Mass/volume] in Serum or Plasma --peak	Theophylline Peak SerPl-mCnc	null	ACTIVE	2.70	2.7
97164-8	Triiodothyronine	MRat	24H	Urine	Qn	null	CHEM	1	Triiodothyronine (T3) [Mass/time] in 24 hour Urine	T3 24h Ur-mRate	null	ACTIVE	2.70	2.7
97165-5	Triiodothyronine	SRat	24H	Urine	Qn	null	CHEM	1	Triiodothyronine (T3) [Moles/time] in 24 hour Urine	T3 24h Ur-sRate	null	ACTIVE	2.70	2.7
97166-3	Thyroxine	MRat	24H	Urine	Qn	null	CHEM	1	Thyroxine (T4) [Mass/time] in 24 hour Urine	T4 24h Ur-mRate	null	ACTIVE	2.70	2.7
97167-1	Thyroxine	SRat	24H	Urine	Qn	null	CHEM	1	Thyroxine (T4) [Moles/time] in 24 hour Urine	T4 24h Ur-sRate	null	ACTIVE	2.70	2.7
97168-9	Vasopressin	MRat	24H	Urine	Qn	null	CHEM	1	Vasopressin [Mass/time] in 24 hour Urine	Vasopressin 24h Ur-mRate	null	ACTIVE	2.70	2.7
97169-7	Vasopressin	SRat	24H	Urine	Qn	null	CHEM	1	Vasopressin [Moles/time] in 24 hour Urine	Vasopressin 24h Ur-sRate	null	ACTIVE	2.70	2.7
9717-0	Toxocara canis Ab.IgA	ACnc	Pt	Ser	Qn	IA	MICRO	1	Toxocara canis IgA Ab [Units/volume] in Serum by Immunoassay	T canis IgA Ser IA-aCnc	null	ACTIVE	1.0i	2.68
97170-5	Adalimumab^trough	MCnc	Pt	Ser/Plas	Qn	null	DRUG/TOX	1	Adalimumab [Mass/volume] in Serum or Plasma --trough	Adalimumab Trough SerPl-mCnc	null	ACTIVE	2.70	2.7
97171-3	Hexacarboxylporphyrin/Creatinine	SRto	Pt	Urine	Qn	null	CHEM	1	Hexacarboxylporphyrin/Creatinine [Molar ratio] in Urine	Hexa-CP/Creat Ur-sRto	null	ACTIVE	2.70	2.7
97172-1	Yersinia outer protein Ab panel	-	Pt	Ser	-	Line blot	PANEL.MICRO	1	Yersinia outer protein Ab panel - Serum by Line blot	Yop Ab Pnl Ser Line blot	null	ACTIVE	2.70	2.7

97084-8

Effect of Facebook as source of information on mental health

Find

Pt

^Patient

Ord

null

SURVEY.COVID

4

Effect of Facebook as source of information on mental health

null

ACTIVE

2.70

2.71

97085-5

Effect of Instagram or Snapchat as source of information on mental health

Find

Pt

^Patient

Ord

null

SURVEY.COVID

4

Effect of Instagram or Snapchat as source of information on mental health

null

ACTIVE

2.70

2.71

97086-3

Effect of Twitter as source of information on mental health

Find

Pt

^Patient

Ord

null

SURVEY.COVID

4

Effect of Twitter as source of information on mental health

null

ACTIVE

2.70

2.71

97087-1

Effect of social media (e.g., TikTok, Reddit) as source of information on mental health

Find

Pt

^Patient

Ord

null

SURVEY.COVID

4

Effect of social media (e.g., TikTok, Reddit) as source of information on mental health

null

ACTIVE

2.70

2.71

97088-9

How often friends, family or neighbors used as source of information for COVID-19

Find

Pt

^Patient

Ord

null

SURVEY.COVID

4

How often friends, family or neighbors used as source of information for COVID-19

null

ACTIVE

2.70

2.71

9708-9

Coxiella burnetii phase 1 Ab.IgG

Titr

Pt

Ser

Qn

null

MICRO

1

Coxiella burnetii phase 1 IgG Ab [Titer] in Serum

C burnet Ph1 IgG Titr Ser

null

ACTIVE

1.0i

2.73

97089-7

How often medical providers used as source of information for COVID-19

Find

Pt

^Patient

Ord

null

SURVEY.COVID

4

How often medical providers used as source of information for COVID-19

null

ACTIVE

2.70

2.71

97090-5

How often local government officials used as source of information for COVID-19

Find

Pt

^Patient

Ord

null

SURVEY.COVID

4

How often local government officials used as source of information for COVID-19

null

ACTIVE

2.70

2.71

97091-3

How often Federal Government used as source of information for COVID-19

Find

Pt

^Patient

Ord

null

SURVEY.COVID

4

How often Federal Government used as source of information for COVID-19

null

ACTIVE

2.70

2.71

97092-1

How often medical or health websites used as source of information for COVID-19

Find

Pt

^Patient

Ord

null

SURVEY.COVID

4

How often medical or health websites used as source of information for COVID-19

null

ACTIVE

2.70

2.71

97093-9

How often print or online news used as source of information for COVID-19

Find

Pt

^Patient

Ord

null

SURVEY.COVID

4

How often print or online news used as source of information for COVID-19

null

ACTIVE

2.70

2.71

97094-7

How often TV or radio used as source of information for COVID-19

Find

Pt

^Patient

Ord

null

SURVEY.COVID

4

How often TV or radio used as source of information for COVID-19

null

ACTIVE

2.70

2.71

97095-4

How often social media used as source of information for COVID-19

Find

Pt

^Patient

Ord

null

SURVEY.COVID

4

How often social media used as source of information for COVID-19

null

ACTIVE

2.70

2.71

97096-2

COVID-19 experiences - media use panel

-

Pt

^Patient

-

COVEX

PANEL.SURVEY.COVID

4

COVID-19 experiences - media use panel [COVEX]

null

ACTIVE

2.70

2.71

9709-7

Coxiella burnetii phase 2 Ab.IgG

Titr

Pt

Ser

Qn

null

MICRO

1

Coxiella burnetii phase 2 IgG Ab [Titer] in Serum

C burnet Ph2 IgG Titr Ser

null

ACTIVE

1.0i

2.73

97097-0

SARS coronavirus 2 Ag

PrThr

Pt

Respiratory.upper

Ord

IA.rapid

MICRO

1

SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

SARS-CoV-2 Ag Upper resp Ql IA.rapid

null

ACTIVE

2.70

2.7

97098-8

SARS coronavirus 2 Nsp2 gene

PrThr

Pt

Respiratory.upper

Ord

Probe.amp.tar

MICRO

1

SARS-CoV-2 (COVID-19) Nsp2 gene [Presence] in Upper respiratory specimen by NAA with probe detection

SARS-CoV-2 Nsp2 Upper resp Ql NAA+probe

null

ACTIVE

2.70

2.7

97099-6

Influenza virus A & Influenza virus B & SARS coronavirus 2 Ag panel

-

Pt

Respiratory.upper

-

IA.rapid

PANEL.MICRO

1

Influenza virus A and B and SARS-CoV-2 (COVID-19) Ag panel - Upper respiratory specimen by Rapid immunoassay

FLUABV+SARS-CoV2 Ag Pnl Up resp IA.rapid

null

ACTIVE

2.70

2.7

97100-2

Colonoscopy and endoscopic ultrasound study

Find

Pt

Lower GI tract

Doc

Colonoscopy+US

ENDO.GI

2

Colonoscopy+US Study

null

ACTIVE

2.70

2.72

97101-0

Flexible sigmoidoscopy and endoscopic ultrasound study

Find

Pt

Lower GI tract

Doc

Flexible sigmoidoscopy+US

ENDO.GI

2

Flexible sigmoidoscopy+US Study

FSIG+US Study

null

ACTIVE

2.70

2.72

97102-8

Tau protein.phosphorylated 181/Amyloid beta 42 peptide

Ratio

Pt

CSF

Qn

null

CHEM

1

Phosphorylated tau 181/Amyloid beta 42 peptide [Ratio] in Cerebral spinal fluid

p-tau181/AL beta42 CSF-Rto

null

ACTIVE

2.70

2.7

97103-6

Zygosity

Type

Pt

^Fetuses

Nom

Molgen

MOLPATH

1

Zygosity [Type] in Fetuses by Molecular genetics method

Zygosity in Fetuses

null

ACTIVE

2.70

2.7

97104-4

SARS coronavirus 2 ORF1ab region

ACnc

Pt

Respiratory.upper

Qn

Probe.amp.tar

MICRO

1

SARS-CoV-2 (COVID-19) ORF1ab region [Units/volume] (viral load) in Upper respiratory specimen by NAA with probe detection

SARS-CoV-2 ORF1ab U resp NAA+probe-aCnc

null

ACTIVE

2.70

2.7

9710-5

Coxiella burnetii phase 1 Ab.IgM

Titr

Pt

Ser

Qn

null

MICRO

1

Coxiella burnetii phase 1 IgM Ab [Titer] in Serum

C burnet Ph1 IgM Titr Ser

null

ACTIVE

1.0i

2.73

97105-1

Chemokine (C-C motif) ligand 2

MCnc

Pt

Urine

Qn

IA

CHEM

1

Chemokine (C-C motif) ligand 2 [Mass/volume] in Urine by Immunoassay

CCL2 Ur IA-mCnc

null

ACTIVE

2.70

2.7

97106-9

Hepatitis A virus cellular receptor 1

MCnc

Pt

Urine

Qn

IA

CHEM

1

Hepatitis A virus cellular receptor 1 [Mass/volume] in Urine by Immunoassay

HAVcr-1 Ur IA-mCnc

null

ACTIVE

2.70

2.7

97107-7

Fibroblast growth factor 19

MCnc

Pt

Ser/Plas

Qn

IA

CHEM

1

Fibroblast growth factor 19 [Mass/volume] in Serum or Plasma by Immunoassay

FGF-19 SerPl IA-mCnc

null

ACTIVE

2.70

2.7

97108-5

Employment status in the 2W prior to COVID-19 outbreak

Find

Pt

^Patient

Nom

null

SURVEY.COVID

4

Employment status in the 2 weeks prior to COVID-19 outbreak

null

ACTIVE

2.70

2.71

97109-3

New employment during the COVID-19 outbreak

Find

Pt

^Patient

Ord

null

SURVEY.COVID

4

New employment during the COVID-19 outbreak

null

ACTIVE

2.70

2.71

97110-1

Work setting in the 2W before the COVID-19 outbreak

Find

Pt

^Patient

Nom

null

SURVEY.COVID

4

Work setting in the 2 weeks before the COVID-19 outbreak

null

ACTIVE

2.70

2.71

97111-9

Job loss during the COVID-19 outbreak

Find

Pt

^Patient

Nom

null

SURVEY.COVID

4

Job loss during the COVID-19 outbreak

null

ACTIVE

2.70

2.71

97112-7

Worked during the COVID-19 outbreak

Find

Pt

^Patient

Ord

null

SURVEY.COVID

4

Worked during the COVID-19 outbreak

null

ACTIVE

2.70

2.71

9711-3

Coxiella burnetii phase 2 Ab.IgM

Titr

Pt

Ser

Qn

null

MICRO

1

Coxiella burnetii phase 2 IgM Ab [Titer] in Serum

C burnet Ph2 IgM Titr Ser

null

ACTIVE

1.0i

2.73

97113-5

Significant job changes during the COVID-19 outbreak

Find

Pt

^Patient

Nom

null

SURVEY.COVID

4

Significant job changes during the COVID-19 outbreak

null

ACTIVE

2.70

2.71

97114-3

Work setting during the COVID-19 outbreak

Find

Pt

^Patient

Nom

null

SURVEY.COVID

4

Work setting during the COVID-19 outbreak

null

ACTIVE

2.70

2.71

97115-0

Student in the few weeks before COVID-19 outbreak

Find

Pt

^Patient

Ord

null

SURVEY.COVID

4

Student in the few weeks before COVID-19 outbreak

null

ACTIVE

2.70

2.71

97116-8

Student during the COVID-19 outbreak

Find

Pt

^Patient

Ord

null

SURVEY.COVID

4

Student during the COVID-19 outbreak

null

ACTIVE

2.70

2.71

97117-6

School has offered classes remotely during the COVID-19 outbreak

Find

Pt

^Patient

Ord

null

SURVEY.COVID

4

School has offered classes remotely during the COVID-19 outbreak

null

ACTIVE

2.70

2.71

97118-4

Increase or decrease in schoolwork during the COVID-19 outbreak

Find

Pt

^Patient

Ord

null

SURVEY.COVID

4

Increase or decrease in schoolwork during the COVID-19 outbreak

null

ACTIVE

2.70

2.71

97119-2

Difficulty getting work or schoolwork done because of other responsibilities at home during the COVID-19 outbreak

Find

Pt

^Patient

Ord

null

SURVEY.COVID

4

Difficulty getting work or schoolwork done because of other responsibilities at home during the COVID-19 outbreak

null

ACTIVE

2.70

2.71

971-2

Weak D Ag

PrThr

Pt

RBC^Donor

Ord

null

BLDBK

1

Weak D Ag [Presence] on Red Blood Cells from Donor

Weak D Ag RBC Donr Ql

null

ACTIVE

1.0

2.7

97120-0

Difficulty getting work or schoolwork done because of your home environment during the COIVD-19 outbreak

Find

Pt

^Patient

Ord

null

SURVEY.COVID

4

Difficulty getting work or schoolwork done because of your home environment during the COIVD-19 outbreak

null

ACTIVE

2.70

2.71

9712-1

Shigella boydii Ab

Titr

Pt

Ser

Qn

Comp fix

MICRO

1

Shigella boydii Ab [Titer] in Serum by Complement fixation

S boydii Ab Titr Ser CF

null

ACTIVE

1.0i

2.73

97121-8

Household job or income loss due to the COVID-19 outbreak

Find

Pt

^Patient

Ord

null

SURVEY.COVID

4

Household job or income loss due to the COVID-19 outbreak

null

ACTIVE

2.70

2.71

97122-6

Person who lost job or income due to COVID-19 outbreak

Find

Pt

^Household member

Nom

null

SURVEY.COVID

4

Household member who lost job or income due to COVID-19 outbreak

null

ACTIVE

2.70

2.71

97123-4

COVID-19 experiences - employment and school changes panel

-

Pt

^Patient

-

COVEX

PANEL.SURVEY.COVID

4

COVID-19 experiences - employment and school changes panel [COVEX]

null

ACTIVE

2.70

2.71

97124-2

How helpful has texting, calling or video-calling family members or friends been as a coping strategy during the COVID-19 outbreak

Find

Pt

^Patient

Ord

null

SURVEY.COVID

4

How helpful has texting, calling or video-calling family members or friends been as a coping strategy during the COVID-19 outbreak

null

ACTIVE

2.70

2.71

97125-9

How helpful has talking to a therapist been as a coping strategy during the COVID-19 outbreak

Find

Pt

^Patient

Ord

null

SURVEY.COVID

4

How helpful has talking to a therapist been as a coping strategy during the COVID-19 outbreak

null

ACTIVE

2.70

2.71

97126-7

How helpful has exercising or walking been as a coping strategy during the COVID-19 outbreak

Find

Pt

^Patient

Ord

null

SURVEY.COVID

4

How helpful has exercising or walking been as a coping strategy during the COVID-19 outbreak

null

ACTIVE

2.70

2.71

97127-5

How helpful has cooking or baking been as a coping strategy during the COVID-19 outbreak

Find

Pt

^Patient

Ord

null

SURVEY.COVID

4

How helpful has cooking or baking been as a coping strategy during the COVID-19 outbreak

null

ACTIVE

2.70

2.71

97128-3

How helpful have arts and crafts projects been as a coping strategy during the COVID-19 outbreak

Find

Pt

^Patient

Ord

null

SURVEY.COVID

4

How helpful have arts and crafts projects been as a coping strategy during the COVID-19 outbreak

null

ACTIVE

2.70

2.71

97129-1

How helpful has cleaning or doing household chores been as a coping strategy during the COVID-19 outbreak

Find

Pt

^Patient

Ord

null

SURVEY.COVID

4

How helpful has cleaning or doing household chores been as a coping strategy during the COVID-19 outbreak

null

ACTIVE

2.70

2.71

97130-9

How helpful has playing games with family members been as a coping strategy during the COVID-19 outbreak

Find

Pt

^Patient

Ord

null

SURVEY.COVID

4

How helpful has playing games with family members been as a coping strategy during the COVID-19 outbreak

null

ACTIVE

2.70

2.71

97131-7

How helpful has playing online games been as a coping strategy during the COVID-19 outbreak

Find

Pt

^Patient

Ord

null

SURVEY.COVID

4

How helpful has playing online games been as a coping strategy during the COVID-19 outbreak

null

ACTIVE

2.70

2.71

97132-5

How helpful has virtual entertainment been as a coping strategy during the COVID-19 outbreak

Find

Pt

^Patient

Ord

null

SURVEY.COVID

4

How helpful has virtual entertainment been as a coping strategy during the COVID-19 outbreak

null

ACTIVE

2.70

2.71

97133-3

Helpful coping strategy used during the COVID-19 outbreak

Find

Pt

^Patient

Nom

null

SURVEY.COVID

4

Helpful coping strategy used during the COVID-19 outbreak

null

ACTIVE

2.70

2.71

97134-1

How helpful was your coping strategy during the COVID-19 outbreak

Find

Pt

^Patient

Ord

null

SURVEY.COVID

4

How helpful was your coping strategy during the COVID-19 outbreak

null

ACTIVE

2.70

2.71

97135-8

Impact of COVID-19 outbreak on life

Find

Pt

^Patient

Ord

null

SURVEY.COVID

4

Impact of COVID-19 outbreak on life

null

ACTIVE

2.70

2.71

97136-6

How helpful has texting, calling or video-calling family members or friends been as a coping strategy to your child during the COVID-19 outbreak

Find

Pt

^Patient

Ord

null

SURVEY.COVID

4

How helpful has texting, calling or video-calling family members or friends been as a coping strategy to your child during the COVID-19 outbreak

null

ACTIVE

2.70

2.71

97137-4

How helpful has virtual learning or school been as a coping strategy to your child during the COVID-19 outbreak

Find

Pt

^Patient

Ord

null

SURVEY.COVID

4

How helpful has virtual learning or school been as a coping strategy to your child during the COVID-19 outbreak

null

ACTIVE

2.70

2.71

97138-2

How helpful has talking to a therapist been as a coping strategy to your child during the COVID-19 outbreak

Find

Pt

^Patient

Ord

null

SURVEY.COVID

4

How helpful has talking to a therapist been as a coping strategy to your child during the COVID-19 outbreak

null

ACTIVE

2.70

2.71

9713-9

Shigella dysenteriae Ab

Titr

Pt

Ser

Qn

Comp fix

MICRO

1

Shigella dysenteriae Ab [Titer] in Serum by Complement fixation

S dysenter Ab Titr Ser CF

null

ACTIVE

1.0i

2.73

97139-0

How helpful has exercising or walking been as a coping strategy to your child during the COVID-19 outbreak

Find

Pt

^Patient

Ord

null

SURVEY.COVID

4

How helpful has exercising or walking been as a coping strategy to your child during the COVID-19 outbreak

null

ACTIVE

2.70

2.71

97140-8

How helpful has cooking or baking been as a coping strategy to your child during the COVID-19 outbreak

Find

Pt

^Patient

Ord

null

SURVEY.COVID

4

How helpful has cooking or baking been as a coping strategy to your child during the COVID-19 outbreak

null

ACTIVE

2.70

2.71

97141-6

How helpful have arts and crafts projects been as a coping strategy to your child during the COVID-19 outbreak

Find

Pt

^Patient

Ord

null

SURVEY.COVID

4

How helpful have arts and crafts projects been as a coping strategy to your child during the COVID-19 outbreak

null

ACTIVE

2.70

2.71

97142-4

How helpful has playing board games, cards with family members been as a coping strategy to your child during the COVID-19 outbreak

Find

Pt

^Patient

Ord

null

SURVEY.COVID

4

How helpful has playing board games, cards with family members been as a coping strategy to your child during the COVID-19 outbreak

null

ACTIVE

2.70

2.71

97143-2

How helpful has playing online games been as a coping strategy to your child during the COVID-19 outbreak

Find

Pt

^Patient

Ord

null

SURVEY.COVID

4

How helpful has playing online games been as a coping strategy to your child during the COVID-19 outbreak

null

ACTIVE

2.70

2.71

97144-0

How helpful has virtual entertainment been as a coping strategy to your child during the COVID-19 outbreak

Find

Pt

^Patient

Ord

null

SURVEY.COVID

4

How helpful has virtual entertainment been as a coping strategy to your child during the COVID-19 outbreak

null

ACTIVE

2.70

2.71

97145-7

Helpful coping strategy your child used during the COVID-19 outbreak

Find

Pt

^Patient

Nom

null

SURVEY.COVID

4

Helpful coping strategy your child used during the COVID-19 outbreak

null

ACTIVE

2.70

2.71

97146-5

How helpful was your child's coping strategy during the COVID-19 outbreak

Find

Pt

^Patient

Ord

null

SURVEY.COVID

4

How helpful was your child's coping strategy during the COVID-19 outbreak

null

ACTIVE

2.70

2.71

9714-7

Shigella flexneri Ab

Titr

Pt

Ser

Qn

Comp fix

MICRO

1

Shigella flexneri Ab [Titer] in Serum by Complement fixation

S flexneri Ab Titr Ser CF

null

ACTIVE

1.0i

2.73

97147-3

COVID-19 experiences - coping panel

-

Pt

^Patient

-

COVEX

PANEL.SURVEY.COVID

4

COVID-19 experiences - coping panel [COVEX]

null

ACTIVE

2.70

2.71

97148-1

Guanidinoacetate

SCnc

Pt

Urine

Qn

null

CHEM

1

Guanidinoacetate [Moles/volume] in Urine

Guanidinoacetate Ur-sCnc

null

ACTIVE

2.70

2.7

97149-9

Pro prostate specific Ag isoform 2

MCnc

Pt

Ser/Plas

Qn

IA

CHEM

1

proPSA isoform 2 [Mass/volume] in Serum or Plasma by Immunoassay

proPSA isoform 2 SerPl IA-mCnc

null

ACTIVE

2.70

2.7

97150-7

Prostate health index

Score

Pt

Ser/Plas

Qn

Calculated

CHEM

1

Prostate health index in Serum or Plasma by calculation

PHI Score SerPl Calc

null

ACTIVE

2.70

2.7

97151-5

Enterovirus RNA

PrThr

Pt

Ser/Plas

Ord

Non-probe.amp.tar

MICRO

1

Enterovirus RNA [Presence] in Serum or Plasma by NAA with non-probe detection

EV RNA SerPl Ql NAA+non-probe

null

ACTIVE

2.70

2.7

97152-3

Hepatitis B virus core+little e+p22cr Ag

ACnc

Pt

Ser/Plas

Qn

IA

MICRO

1

HBc+HBe+p22cr Ag [Units/volume] in Serum or Plasma by Immunoassay

HBc+HBe+p22cr Ag SerPl IA-aCnc

null

ACTIVE

2.70

2.7

97153-1

Primidone

PrThr

Pt

Urine

Ord

Confirm

DRUG/TOX

1

Primidone [Presence] in Urine by Confirmatory method

Primidone Ur Ql Cfm

null

ACTIVE

2.70

2.7

9715-4

Shigella sonnei Ab

Titr

Pt

Ser

Qn

Comp fix

MICRO

1

Shigella sonnei Ab [Titer] in Serum by Complement fixation

S sonnei Ab Titr Ser CF

null

ACTIVE

1.0i

2.73

97154-9

Ecgonine methyl ester

PrThr

Pt

Urine

Ord

Confirm

DRUG/TOX

1

Ecgonine methyl ester [Presence] in Urine by Confirmatory method

EME Ur Ql Cfm

null

ACTIVE

2.70

2.7

97155-6

SARS coronavirus 2 immunization status

Hx

Pt

^Patient

Nom

null

VACCIN

2

SARS coronavirus 2 (COVID-19) immunization status

SARS-CoV-2 immunization status

null

ACTIVE

2.70

2.7

97156-4

Human papilloma virus 16+18+31+33+35+39+45+51+52+56+58+59+68 DNA

PrThr

Pt

Genital

Ord

Probe.amp.sig

MICRO

1

Human papilloma virus 16+18+31+33+35+39+45+51+52+56+58+59+68 DNA [Presence] in Genital specimen by Probe with signal amplification

HPV I/H Risk DNA Genital Ql Prb+sig amp

null

ACTIVE

2.70

2.7

97157-2

Human papilloma virus 6+11+42+43+44 DNA

PrThr

Pt

Genital

Ord

Probe.amp.sig

MICRO

1

Human papilloma virus 6+11+42+43+44 DNA [Presence] in Genital specimen by Probe with signal amplification

HPV Low Risk DNA Genital Ql Prb+sig amp

null

ACTIVE

2.70

2.7

97158-0

Cytokeratin 8 Ag

PrThr

Pt

Tissue

Ord

Immune stain

PATH

1

Cytokeratin 8 Ag [Presence] in Tissue by Immune stain

CK8 Ag tiss Ql ImStn

null

ACTIVE

2.70

2.7

97159-8

2-Hydroxyethylflurazepam

MCnc

Pt

Urine

Qn

Confirm

DRUG/TOX

1

2-Hydroxyethylflurazepam [Mass/volume] in Urine by Confirmatory method

2-OH-Ethylfluraz Ur Cfm-mCnc

null

ACTIVE

2.70

2.7

97160-6

Norclobazam

MCnc

Pt

Urine

Qn

Confirm

DRUG/TOX

1

Norclobazam [Mass/volume] in Urine by Confirmatory method

Norclobazam Ur Cfm-mCnc

null

ACTIVE

2.70

2.7

97161-4

Amphetamines panel

-

Pt

Urine

-

Confirm

PANEL.DRUG/TOX

1

Amphetamines panel - Urine by Confirmatory method

Amphetamines Pnl Ur Cfm

null

ACTIVE

2.70

2.7

9716-2

Streptococcal hyaluronidase Ab

Titr

Pt

Ser

Qn

null

MICRO

1

Streptococcal hyaluronidase Ab [Titer] in Serum

Str Hyaluronidase Ab Titr Ser

null

ACTIVE

1.0i

2.7

97162-2

Titin Ab

ACnc

Pt

CSF

Qn

Line blot

SERO

1

Titin Ab [Units/volume] in Cerebral spinal fluid by Line blot

Titin Ab CSF Line blot-aCnc

null

ACTIVE

2.70

2.7

97163-0

Theophylline^peak

MCnc

Pt

Ser/Plas

Qn

null

DRUG/TOX

1

Theophylline [Mass/volume] in Serum or Plasma --peak

Theophylline Peak SerPl-mCnc

null

ACTIVE

2.70

2.7

97164-8

Triiodothyronine

MRat

24H

Urine

Qn

null

CHEM

1

Triiodothyronine (T3) [Mass/time] in 24 hour Urine

T3 24h Ur-mRate

null

ACTIVE

2.70

2.7

97165-5

Triiodothyronine

SRat

24H

Urine

Qn

null

CHEM

1

Triiodothyronine (T3) [Moles/time] in 24 hour Urine

T3 24h Ur-sRate

null

ACTIVE

2.70

2.7

97166-3

Thyroxine

MRat

24H

Urine

Qn

null

CHEM

1

Thyroxine (T4) [Mass/time] in 24 hour Urine

T4 24h Ur-mRate

null

ACTIVE

2.70

2.7

97167-1

Thyroxine

SRat

24H

Urine

Qn

null

CHEM

1

Thyroxine (T4) [Moles/time] in 24 hour Urine

T4 24h Ur-sRate

null

ACTIVE

2.70

2.7

97168-9

Vasopressin

MRat

24H

Urine

Qn

null

CHEM

1

Vasopressin [Mass/time] in 24 hour Urine

Vasopressin 24h Ur-mRate

null

ACTIVE

2.70

2.7

97169-7

Vasopressin

SRat

24H

Urine

Qn

null

CHEM

1

Vasopressin [Moles/time] in 24 hour Urine

Vasopressin 24h Ur-sRate

null

ACTIVE

2.70

2.7

9717-0

Toxocara canis Ab.IgA

ACnc

Pt

Ser

Qn

IA

MICRO

1

Toxocara canis IgA Ab [Units/volume] in Serum by Immunoassay

T canis IgA Ser IA-aCnc

null

ACTIVE

1.0i

2.68

97170-5

Adalimumab^trough

MCnc

Pt

Ser/Plas

Qn

null

DRUG/TOX

1

Adalimumab [Mass/volume] in Serum or Plasma --trough

Adalimumab Trough SerPl-mCnc

null

ACTIVE

2.70

2.7

97171-3

Hexacarboxylporphyrin/Creatinine

SRto

Pt

Urine

Qn

null

CHEM

1

Hexacarboxylporphyrin/Creatinine [Molar ratio] in Urine

Hexa-CP/Creat Ur-sRto

null

ACTIVE

2.70

2.7

97172-1

Yersinia outer protein Ab panel

-

Pt

Ser

-

Line blot

PANEL.MICRO

1

Yersinia outer protein Ab panel - Serum by Line blot

Yop Ab Pnl Ser Line blot

null

ACTIVE

2.70

2.7